期刊文献+

小而密低密度脂蛋白与冠心病的相关性研究 被引量:16

Relationship between small,dense low-density lipoprotein and coronary heart disease
暂未订购
导出
摘要 目的探讨血清小而密低密度脂蛋白(sdLDL)水平与冠心病(CHD)发生发展的关系。方法选取冠心病患者105例作为病例组,包括稳定性心绞痛(SAP)组36例、不稳定性心绞痛(UAP)组39例和急性心肌梗死(AMI)组30例。另取30例体格检查正常,一般资料与病例组相匹配的体检者为对照组,测定各组血清sdLDL水平并进行比较。同时将SAP、UAP、AMI组的sdLDL与冠心病冠脉狭窄程度(Gensini评分)进行相关性分析。结果冠心病组sdLDL水平较对照组明显增高(P<0.05),有统计学意义。SAP、UAP、AMI各组sdLDL水平与对照组比较,均明显增高(P<0.05)。SAP,UAP,AMI组间两两比较无统计学差异(P>0.05)。三组患者sdLDL与冠脉狭窄程度(Gensini积分)相关性:SAP患者sdLDL水平与冠脉狭窄程度(Gensini积分)无明显相关性。UAP,AMI患者的sdLDL水平与冠脉狭窄程度(Gensini积分)成明显正相关。结论研究结果显示sdLDL升高是发生冠心病的一个重要因素,sdLDL对于预测有无冠状动脉病变及其病情进展有一定临床意义。 [Objective] To investigate the relationship between the serum level of small dense low-density lipoprotein (sdLDL) with coronary heart disease. [Methods] A total of 105 patients with coronary heart disease without hypertension and smoking history as the coronary heart disease (CHD) group, were divided into 3 groups, including the stable angina pectoiis (SAP) group (36 cases), the unstable angina pectoris (UAP) group (39 eases) and the acute myocardial infarction (AMI) group (30 cases), another 30 patients with normal coronary angiograpby served as control group (30 cases). The serum sdLDL was detected using the two-point end assay. Meanwhile the severity of coronary artery stenosis was quantautively assessed by Gensini score. [ Results ] The level of sdLDL in all the CHD groups was higher than that in control group (P 〈0.05). The severity of coronary artery stenosis defined by Gensini score was positively correlated with the sdLDL level in UAP and AMI group, but not in SAP group. [ Conclusions] These date suggested increased sdLDL plays a major role in the development of coronary disease and sdLDL can be a valuable index for the diagnosis and progress of CHD.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第27期3376-3379,共4页 China Journal of Modern Medicine
基金 江苏省厅"科教兴卫工程"医学重点学科开放性课题(No:xk200723)
关键词 冠心病 稳定性心绞痛 不稳定性心绞痛 急性心肌梗死 小而密低密度脂蛋白 coronary heart disease stable angina pectoris unstable angina pectoris acute myocardial infarction small dense low-density lipoprotein
  • 相关文献

参考文献14

  • 1RIZZO M, BEMEIS K. Low-density lipoprotein size and cardio- vascular risk assessment[J]. QJM, 2006, 99(1): 1-14.
  • 2TOFT-PETERSEN AP, TISTED HH, AAROE J, et at. Small dense LDL particles--a predictor of coronary .artery disease e- valuated by invasive and CT-based techniques: a case-control study[J]. Lipids Health Dis, 2011, 10:21.
  • 3PACKARD CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease [J]. Curr Opin Lipidol, 2006, 17(4): 412-417.
  • 4Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third re-port of the National Cholesterol Education Program (NCEP) Ex- pert Panel on Detection,Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ )[R]. JAMA, 2001, 285(19): 2486-2497.
  • 5LAMARCHEB, TCHERNOF dense low-density lipoprotein of ischemic heart disease in A, MOORJANI S, et al. Small particles as a predictor of the risk men: Prospective results from the Quebec cardiovascular Study[J]. Circulation, 1997, 95:69-75.
  • 6WANG H, WANG HM, JIN QH, et al. Microchip-based small, dense low-density lipoproteins assay for coronary heart disease risk assessment[J]. Electrophoresis, 2008, 29: 1932-1941.
  • 7JUNGNER I, SNIDERMAN AD, FURBERG C, et al. Dose low-density lipoprotein size add to atherogenie particle number in predicting the risk of fatal myocardial infarction [J]. Am J Cardiol, 2006, 97: 943-946.
  • 8秦勤,耿婕,崔让庄,毛用敏,寇璐,赵炳让,惠汝太.冠心病患者血浆纤维蛋白原与小而密低密度脂蛋白的关系[J].中华心血管病杂志,2003,31(8):584-587. 被引量:21
  • 9PATEL JV, CASAKE M J, VVAS A, et al. Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations [J]. Atheroscerosis, 2010, 209(2): 579-584.
  • 10KWON SW, YOON SJ, KANQ TS, et al. Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome [J]. Yonsei Med J, 2006, 47(3): 405-414.

二级参考文献16

  • 1[1]Rizzo M, Barbagallo CM, Severino M, et al. Low-density-lipoprotein peak particle size in a Mediterranean population. Europ J Clin Invest,2003,33(2) :126-133.
  • 2[2]Otvos JD, Shalanrova I, Freedman DS, et al. Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial. Atherosclerosis ,2002,160 ( 1 ) :241-253.
  • 3[3]Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res, 1982,23 ( 1 ) :97-104.
  • 4[4]Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterm and risk of myocardial infartian. JAMA, 1998,260(13) :1917-1921.
  • 5[5]Kwiterovich PO Jr. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardicl,2002,90(8A) :30-47.
  • 6[6]Koba S,Hirano T,Kondo T,et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. Am Heart J,2002,144 ( 6 ): 1026-1035.
  • 7[7]Stampfer MJ,Krauss RM,Ma J,et al. A prospective study of triglyceride level,low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA, 1996,276 ( 11 ) :882-888.
  • 8[8]Yoshino G, Hirano T, Kasumi T. Treatment of small dense LDL. J Atheroscler Thromb ,2002,9 (6) :266-275.
  • 9[9]Peeples LH, Carpenter JW, Israel RG, et al. Alterations in low - density lipoproteins in subjects with abdominal adiposity. Metabolism, 1989,38(10): 1029-1036.
  • 10Miller BD, Alderman EL, Haskdl WL, et al. Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project. Circulation, 1996, 94: 2146-2153.

共引文献31

同被引文献132

引证文献16

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部